Proteintech’s HumanKine® range of human cell-expressed Proteins are created in HEK293 cells and are ideal for use in human applications.
Using recombinant proteins from a human expression system provides the following benefits:
Product Name | Item number | Activity Spec. | Purity | Citations |
Activin A | HZ-1138-10ug | ≤5 ng/mL EC50 | >95% | 16 |
beta NGF | HZ-1222-100ug | ≤3 ng/mL EC50 | >95% | |
BMP-2 | HZ-1128-10ug | ≤60 ng/mL EC50 | >95% | 21 |
BMP-4 | HZ-1045-10ug | ≤10 ng/mL EC50 | >95% | 41 |
BMP-7 | HZ-1229-10ug | ≤100 ng/mL EC50 | >95% | 6 |
Cystatin C | HZ-1211-10ug | ≤5 µM IC50 | >95% | |
EPO | HZ-1168-100ug | ≤2.5 ng/mL EC50 | >95% | 3 |
FGF Basic TS | HZ-1285-100ug | ≤0.5 ng.mL EC50 | >95% | 8 |
FGF-4 | HZ-1218-100ug | ≤1.25 ng/mL EC50 | >95% | |
FGF-7 (KGF) | HZ-1100-100ug | ≤7.5 ng/mL EC50 | >95% | 1 |
FGF-8b | HZ-1103-100ug | ≤10 ng/mL EC50 | >95% | 1 |
FLT3 Ligand | HZ-1151-100ug | ≤0.8 ng/mL EC50 | >95% | 10 |
G-CSF | HZ-1207-100ug | ≤0.1 ng/mL EC50 | >95% | 6 |
GDNF | HZ-1311-10ug | ≤ 10 ng/mL EC50 | >95% | |
GM-CSF | HZ-1002-100ug | ≤0.5 ng/mL EC50 | >95% | 10 |
HGF | HZ-1084-100ug | ≤20 ng/mL EC50 | >95% | 8 |
HGH | HZ-1007-100ug | ≤0.5 ng/mL EC50 | >95% | 2 |
HSA | HZ-3001-1000ug | N/A | >95% | |
IFN alpha 2A | HZ-1066-100ug | ≤0.4 ng/mL EC50 | >95% | 4 |
IFN alpha 2B | HZ-1072-100ug | ≤0.12 ng/mL EC50 | >95% | 2 |
IFN beta | HZ-1298-100ug | ≤0.1 ng/mL EC50 | >95% | |
IFN gamma | HZ-1301-100ug | ≤0.05 ng/mL EC50 | >95% | 3 |
IL-1 beta | HZ-1164-100ug | ≤0.05 ng/mL EC50 | >95% | 16 |
IL-2 | HZ-1015-100ug | ≤5 ng/mL EC50 | >95% | 5 |
IL-3 | HZ-1074-100ug | ≤2 ng/mL EC50 | >95% | 10 |
IL-4 | HZ-1004-100ug | ≤0.6 ng/mL EC50 | >95% | 17 |
IL-6 | HZ-1019-100ug | ≤0.5 ng/mL EC50 | >95% | 19 |
IL-7 | HZ-1281-100ug | ≤1 ng/mL EC50 | >95% | |
IL-9 | HZ-1240-100ug | ≤1 ng/mL EC50 | >95% | 2 |
IL-10 | HZ-1145-100ug | ≤1.5 ng/mL EC50 | >95% | |
IL-12 | HZ-1256-100ug | ≤2 ng/mL EC50 | >95% | 3 |
IL-17 (IL-17A) | HZ-1113-100ug | ≤2 ng/mL EC50 | >95% | 3 |
IL-17F | HZ-1116-100ug | ≤10 ng/mL EC50 | >95% | |
IL-23 | HZ-1254-100ug | ≤4 ng/mL EC50 | >95% | 11 |
IL-27 | HZ-1275-100ug | ≤12 ng/mL EC50 | >95% | 1 |
IL-28A | HZ-1235-100ug | ≤5 ng/mL EC50 | >95% | 2 |
IL-28B | HZ-1245-100ug | ≤1 ng/mL EC50 | >95% | 3 |
IL-29 | HZ-1156-100ug | ≤5 ng/mL EC50 | >95% | 2 |
Lefty-1 | HZ-1109-100ug | ≤40 ng/mL EC50 | >95% | 1 |
LIF | HZ-1292-100ug | ≤0.2 ng/mL EC50 | >95% | |
M-CSF | HZ-1192-100ug | ≤4 ng/mL EC50 | >95% | 5 |
Noggin | HZ-1118-100ug | ≤15 ng/mL EC50 | >95% | 5 |
Oncostatin M | HZ-1030-100ug | ≤1 ng/mL EC50 | >95% | 3 |
PDGF-aa | HZ-1215-100ug | ≤10 ng/mL EC50 | >95% | |
PDGFbb | HZ-1308-100ug | ≤3 ng/mL EC50 | >95% | 1 |
Pleiotrophin-PTN | HZ-1278-100ug | N/A | >95% | |
pro-IGF-II | HZ-1161-100ug | ≤50 ng/mL EC50 | >95% | 1 |
SCF | HZ-1024-100ug | ≤25 ng/mL EC50 | >95% | 9 |
Sonic Hedgehog (SHH) | HZ-1306-100ug | ≤350 ng/mL EC50 | >90% | |
TGF beta 1 | HZ-1011-100ug | ≤0.5 ng/mL EC50 | >95% | 82 |
TGF beta 2 | HZ-1092-100ug | ≤0.5 ng/mL EC50 | >95% | 4 |
TGF beta 3 | HZ-1090-100ug | ≤0.5 ng/mL EC50 | >95% | 8 |
Thrombin | HZ-3010-1000ug | N/A | >95% | 1 |
TNF alpha | HZ-1014-100ug | ≤0.5 ng/mL EC50 | >95% | 9 |
TPO | HZ-1248-100ug | ≤5 ng/mL EC50 | >95% | 2 |
VEGF 121 | HZ-1204-100ug | ≤15 ng/mL EC50 | >95% | 14 |
VEGF 165 | HZ-1038-100ug | ≤5 ng/mL EC50 | >95% | 11 |
Wnt3A | HZ-1296-100ug | ≤20 ng/mL EC50 | >90% | 1 |